July 19, 2012
Join us next week as Safeguard Scientifics releases its financial results for the second quarter ended June 30, 2012 prior to market open on Thursday, July 26,…
Posted by
Here is a recap of our first quarter 2012 financial results. Our team is executing a focused and disciplined strategy that enhances Safeguard’s brand as…
Posted by
Join us next week when Safeguard Scientifics releases its financial results for the first quarter ended March 31, 2012 prior to market open on Thursday, April 26,…
Posted by
This morning, we announced our fourth quarter and full-year 2011 financial results. Consolidated net loss for the three months ended December 31, 2011 was $24.5…
Posted by
Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…
Posted by
As Peter J. Boni highlighted this morning, despite volatile capital markets and a wobbly economy, Safeguard Scientifics continues to fire on all cylinders by realizing…
Posted by
The IPO Task Force unveiled a new effort to ease the IPO road for emerging companies in its report, “Rebuilding the IPO On-Ramp.” The report…
Posted by
Safeguard Scientifics will release its financial results for the third quarter ended September 30, 2011 prior to market open on Wednesday, October 26. At 9…
Posted by
As another week draws to a close, we’d like to take a minute to look at some developments making their way around the Web and…
Posted by
